Base to Base Biotech
The Base to Base Biotech podcast is a weekly look at what's happening in the world of biotech, with interviews with biotech leaders around the world. Whether it's a new drug, cutting-edge technology, product launches, new technology, major finding announcement or clinical trial results, Base to Base Biotech keeps you informed. The podcast is hosted by former biotech editor and broadcaster, the award-winning media veteran Jim Cornall. Base to Base is an Ayr Coastal Media Ltd production.
Episodes
This week, we chat with Affibody CEO David Bejker, and Martin Gleave, founder and chief medical officer at Sustained Therapeutics.
Times:
03:47 Affibody
23:28 Sustained Therapeutics
Sustained Therapeutics
A spin-out from the University of British Columbia in Canada, Sustained Therapeutics utilises a proprietary polymer gel technology to develop locally injected, long-acting medications. The platform is designed to release active pharmac...
This week, we chat with Pan Cancer T CEO Dr. Rachel Abbott, about – among other things – triple-negative breast cancer. We also have a conversation with Erik Manting, CEO of immunotherapy company Mendus, and Janet Hoogstraate, CEO of the CDMO helping them, North X Biologics.
Times:
03:56 Pan Cancer T
20:23 Mendus/NorthX Biologics
Mendus
Mendus is a Swedish–Dutch immuno-oncology company developing cell-based therapies aimed at stopping c...
This week, we have a conversation with Lisa Guerrettaz, executive director, Pharmacology and Translational Science at Artiva Biotherapeutics; and Avacta Therapeutics’ CEO Christina Coughlin.
Times:
04:12 Artiva Biotherapeutics
21:30 Avacta Therapeutics
Artiva Biotherapeutics
Artiva Biotherapeutics is a clinical‑stage cell therapy company developing off‑the‑shelf (allogeneic) natural killer (NK) cell therapies for autoimmune diseases and...
This week, three interviews, and five guests. We have conversations with Ulrik Tirsted Zeuthen, CEO, and Katarina Cantell, founder/CSO of Adalyon; Nisit Khandelwal, co-founder/CEO, Cycuria Therapeutics; and Craig Ritchie, founder/CEO of Scottish Brain Sciences and Deborah O’Neil, CEO/CSO of NovaBiotics as well as chair of the Life Sciences board of Opportunity Northeast, which runs ONE BioHub, and BioAberdeen.
Times:
02:38 Adalyon
32:...
This week, we’re talking about eye treatments with Oculis CEO, Riad Sherif, we have a conversation about mitochondria, with the CEO of Vandria, Klaus Dugi, and there’s also a short discussion about GoCo Health Innovation City in Gothenburg, Sweden, with Moa Dicksdotter, Partnership and Ecosystem.
Times:
02:35 Vandria
20:03 GoCo Health Innovation City
25:54 Oculis
Looking to the eyes
Oculis is a Swiss ophthalmology company developing topi...
This week, we’re talking about skin and wounds, with Ned Swanson, president and chief medical officer at PolarityBio, and Nikolai Sopko, chief operating officer, chief scientific officer and director at PolarityBio; and we discuss anchored immunotherapy with Howard Kaufman, CEO of Ankyra Therapeutics.
04:03 Ankyra Therapeutics
34:31 PolarityBio
Anchored immunotherapies
Ankyra Therapeutics, based in Cambridge, Massachusetts, develops an...
This week, we have conversations with Jakob Andersson, vice president of engineering at Anaphora and founder and chairman of GAIA; Coave Therapeutics’ CEO Rodolphe Clerval; and MOBILion Systems’ CEO, Melissa Sherman.
Times:
03:13 Coave Therapeutics
24:43 GAIA Conference
36:55 MOBILion Systems
Genetic medicine for ophthalmology
Coave Therapeutics is a Paris‑based biotechnology company focused on developing genetic medicines using its AL...
Base to Base biotech podcast 38: Obesity, life sciences in the Netherlands, and killing cancer cells
This week, we have conversations with Sjanna Bosma, international relations officer at Health Holland; Mark Bagnall, CEO of Phenomix; and PDS Biotechnology CEO Frank Bedu-Addo.
04:17 Phenomix
32:53 Health Holland
44:02 PDS Biotechnology
Phenomix takes on obesity
Phenomix Sciences is a biotechnology company focused on precision obesity medicine. The firm has developed the MyPhenome test, a saliva‑based assay that uses machine‑learning ...
This week, we have conversations with Jérôme Van Biervliet, chair of the board of Flanders life sciences body Biovia and managing director at VIB; Sylvain Sachot, partner at Asabys Partners; and Jonas Béal, head of science strategy, R&D, at Owkin.
03:32 Owkin
27:42 Biovia/VIB
38:06 Asabys Partners
Biovia/VIB
Biovia has emerged as a new health innovation cluster in the Belgian region of Flanders, created through the merger of flan...
This week, we have conversations with Robert Bunn, founder and president of Ultrasound AI; Laura MacNeill, CEO of the Charcot Marie Tooth Research Foundation; and Iris Örhn, investment advisor at Business Region Göteborg.
03:00 Ultrasound AI
30:19 Business Region Gothenburg
39:35 CMTRF
Business Region Gothenburg
Business Region Gothenburg (BRG) is the regional development agency for western Sweden, tasked with driving growth and innov...
This week, we have conversations with Malin Kjällström, Gothenburg Tech Week Press and partnerships lead; Eliot Forster the CEO of Levicept; and Christophe Demaison, CEO of ENA Respiratory.
Gothenburg Tech Week
Gothenburg Tech Week is western Sweden’s largest technology event, held annually across multiple venues in the city. The 2025 edition ran from October 14–16, with a programme that includes startup and investor matchmaking, the...
It’s World Immunization Day on Monday, so we had a chat with Geovax chairman, president and CEO David Dodd, and in our other conversation, we talked about infertility, with Igyxos Biotherapeutics’ chief medical officer Elke Bestel.
Challenging infertility
Igyxos Biotherapeutics is a French biotechnology company founded in 2017 and based in Nouzilly, France. The company focuses exclusively on infertility, developing monoclonal antibod...
This week, we have conversations with Cosmo Feilding Mellen, CEO of Beckley Psytech; Sirli Rosenvald, CEO of Estonian company Funki, and Per von Mentzer, CEO of Swedish company PharmNovo. We spoke with Funki at Life Sciences Baltics in Vilnius, Lithuania, recently, and with von Mentzer at NLS Days in Gothenburg.
Taking on pain
PharmNovo AB is a biotechnology company headquartered at Medicon Village in Lund, Sweden. Founded in 2008, i...
This week, we have conversations on data integration with Lithuanian company Vugene, and we talk protein degradation with Amphista Therapeutics.
Multi-omics
Vugene is a Lithuanian bioinformatics company focused on multi-omics data integration. Founded in 2021 by CTO Juozas Gordevičius, the company is headquartered in Kaunas.
Its core offering is a software platform designed to help researchers make sense of complex biological datasets...
This week, we have one interview, covering enzymes and AI with Biomatter Designs, from our visit to Life Sciences Baltics in Vilnius, Lithuania recently. And from the trip to Dublin in Ireland we talked about technology that can be useful in neurological condition diagnosis, and much more, with Danu Sports.
Enzymes and AI
Biomatter Designs is a Lithuania‑based biotech working at the frontier of protein design. Since its launch in 201...
This week, we have three interviews done during Life Sciences Baltics, which was held in Vilnius, Lithuania recently.
While we have more still to come, this week on the podcast we have conversations with Justinas Mačiulaitis, Keli Therapeutics’ founder and CEO; Arnas Karužas, CEO of Ligence; and Emilė Radytė, CEO and co-founder of Samphire Neuroscience.
Ligence
Ligence is a health‑tech startup using artificial intelligence to automat...
This week, we have two interviews again. We talk about treating high blood pressure with CEO of George Medicines, Mark Mallon, and have a conversation with Jack Hoppin, CEO of Ratio Therapeutics, and John Babich, CSO, about the field of radiotherapeutics.
Blood pressure
Nearly half of US adults have high blood pressure and despite all the treatments already available, three in four remain uncontrolled. This is often because the tradi...
This week, we have two interviews. We chat with Step Pharma CEO, Andy Parker, and also have a conversation with Re-Vana CEO, Michael O’Rourke.
Ocular therapeutics
Re-Vana Therapeutics and Boehringer Ingelheim recently announced a $1bn+ deal to develop long-acting ophthalmic therapies.
Re-Vana Therapeutics is a privately held, US and UK based developer of ocular therapeutics and innovative ocular drug delivery technologies which spun o...
Base to Base biotech podcast 27: Childhood Cancer Awareness Month and DNA-based technology platforms
This week, we have two interviews: one to mark Childhood Cancer Awareness Month, on osteosarcoma with Paul Romness from OS Therapies; and IMUNON’s CEO, Stacy Lindborg, talking about ovarian cancer, immunotherapy, covid, and more.
Interview times:
02:33 OS Therapies
23:03 IMUNON
Challenging osteosarcoma
OS Therapies is a clinical stage oncology company focused on the identification, development, and commercialisation of treatments for os...
This week, we have three interviews to mark Stand Up To Cancer Day. We have conversations with Simon Kerry, co-founder and CEO of Curve Therapeutics; Poolbeg Pharma CEO Jeremy Skillington; and Stefano Gulla, CSO of Kling Biotherapeutics.
Interview times:
03:12 Curve Therapeutics
21:32 Kling Bio
37:10 Poolbeg Pharma
Microcycles to address cancer
Curve Therapeutics, a private biotechnology company using its gene-encoded Microcycle discover...
Popular Podcasts
Two Guys (Bowen Yang and Matt Rogers). Five Rings (you know, from the Olympics logo). One essential podcast for the 2026 Milan-Cortina Winter Olympics. Bowen Yang (SNL, Wicked) and Matt Rogers (Palm Royale, No Good Deed) of Las Culturistas are back for a second season of Two Guys, Five Rings, a collaboration with NBC Sports and iHeartRadio. In this 15-episode event, Bowen and Matt discuss the top storylines, obsess over Italian culture, and find out what really goes on in the Olympic Village.
Listen to the latest news from the 2026 Winter Olympics.
Gregg Rosenthal and a rotating crew of elite NFL Media co-hosts, including Patrick Claybon, Colleen Wolfe, Steve Wyche, Nick Shook and Jourdan Rodrigue of The Athletic get you caught up daily on all the NFL news and analysis you need to be smarter and funnier than your friends.
The 2026 Winter Olympics in Milan Cortina are here and have everyone talking. iHeartPodcasts is buzzing with content in honor of the XXV Winter Olympics We’re bringing you episodes from a variety of iHeartPodcast shows to help you keep up with the action. Follow Milan Cortina Winter Olympics so you don’t miss any coverage of the 2026 Winter Olympics, and if you like what you hear, be sure to follow each Podcast in the feed for more great content from iHeartPodcasts.
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.